Label Comprehension Results Point Petros Toward OTC Self-Selection Study For Stendra ED Drug
Executive Summary
Petros considers switch NDA for Stendra (avanafil), approved for Rx sales in US since 2012 on an NDA by Metuchen. Early indicators showed positive outcomes in a 453-subject label comprehension study for the oral PDE5 inhibitor.